Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker.
Signorelli D, Giannatempo P, Grazia G, Aiello MM, Bertolini F, Mirabile A, Buti S, Vasile E, Scotti V, Pisapia P, Cona MS, Rolfo C, Malapelle U; Immune-Oncology YOUNG Group. Signorelli D, et al. Among authors: aiello mm. Biomed Res Int. 2019 Apr 24;2019:9056417. doi: 10.1155/2019/9056417. eCollection 2019. Biomed Res Int. 2019. PMID: 31179334 Free PMC article. Review.
A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS study.
Bogani G, Cinquini M, Signorelli D, Pizzutilo EG, Romanò R, Bersanelli M, Raggi D, Alfieri S, Buti S, Bertolini F, Bonomo P, Marandino L, Rizzo M, Monteforte M, Aiello M, Tralongo AC, Torri V, Di Donato V, Giannatempo P. Bogani G, et al. Crit Rev Oncol Hematol. 2023 Jul;187:104016. doi: 10.1016/j.critrevonc.2023.104016. Epub 2023 May 6. Crit Rev Oncol Hematol. 2023. PMID: 37156405 Review.
'Genetic profiling' and ovarian cancer therapy (review).
Vella N, Aiello M, Russo AE, Scalisi A, Spandidos DA, Toffoli G, Sorio R, Libra M, Stivala F. Vella N, et al. Mol Med Rep. 2011 Sep-Oct;4(5):771-7. doi: 10.3892/mmr.2011.512. Epub 2011 Jun 17. Mol Med Rep. 2011. PMID: 21687948 Review.
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis.
Gebbia V, Aiello MM, Banna G, Blanco G, Blasi L, Borsellino N, Giuffrida D, Mauro ML, Mancuso G, Piazza D, Savio G, Parra HS, Valerio MR, Verderame F, Vigneri P. Gebbia V, et al. Among authors: aiello mm. Ecancermedicalscience. 2020 Sep 29;14:1113. doi: 10.3332/ecancer.2020.1113. eCollection 2020. Ecancermedicalscience. 2020. PMID: 33144881 Free PMC article.
23 results